Early-stage non-Spitzoid cutaneous melanoma in patients younger than 22 years of age at diagnosis: long-term follow-up and survival analysis
- PMID: 25819019
- PMCID: PMC4558908
- DOI: 10.1016/j.jpedsurg.2015.03.030
Early-stage non-Spitzoid cutaneous melanoma in patients younger than 22 years of age at diagnosis: long-term follow-up and survival analysis
Abstract
Purpose: We evaluated prognostic factors among young patients with early stage melanoma, with particular attention to survival, recurrence, and development of a second primary melanoma.
Methods: We retrospectively reviewed patients (age <22 years) with pathologically confirmed in-situ and stage 1 non-Spitzoid melanoma treated at our institution from 1980-2010, assessing demographics, clinical presentation, treatment, disease-specific survival, recurrence-free survival, and probability of developing a second primary melanoma.
Results: One hundred patients with in-situ melanoma (n=16) or stage 1A (n=48) or 1B (n=36) melanoma were identified. Median age was 19.4 years (range, 11.2-21.9), and median follow-up was 7.6 years (range, 0.1-31.7). Median tumor thickness was 0.76 mm (range, 0.23-2.0). No lesions were ulcerated. All patients underwent wide local excision with negative margins, and 21 had a concomitant negative sentinel lymph node biopsy (SLNB). Sixteen patients developed recurrences, and 8 subsequently died of progressive melanoma. There were 2 non-melanoma-related deaths. Endpoints were 20-year overall survival (77.4%), melanoma-specific mortality (20.1%), recurrence rate (34.0%), and probability of developing a second primary melanoma (24.7%). Greater tumor depth and Clark level were associated with worse prognosis, but age, sex, and tumor mitotic rate were not correlated with recurrence or survival.
Conclusion: Among younger early-stage melanoma patients, greater lesion depth conferred higher recurrence risk and mortality. Our data did not define the role of sentinel lymph node biopsy in this group.
Keywords: Adolescent; Melanoma; Prognosis; Recurrence.
Copyright © 2015 Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.Ann Surg Oncol. 2015 Sep;22(9):2978-87. doi: 10.1245/s10434-014-4349-3. Epub 2015 Jan 21. Ann Surg Oncol. 2015. PMID: 25605514 Clinical Trial.
-
Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.Plast Reconstr Surg. 2003 Aug;112(2):486-97. doi: 10.1097/01.PRS.0000070989.23469.1F. Plast Reconstr Surg. 2003. PMID: 12900606
-
Is sentinel lymph node biopsy of therapeutic relevance for melanoma?Dermatology. 2004;209(1):5-13. doi: 10.1159/000078580. Dermatology. 2004. PMID: 15237261
-
Optimal excision margins for primary cutaneous melanoma: a systematic review and meta-analysis.Can J Surg. 2003 Dec;46(6):419-26. Can J Surg. 2003. PMID: 14680348 Free PMC article. Review.
-
Staging and prognosis of melanoma.Semin Cutan Med Surg. 1997 Jun;16(2):113-21. doi: 10.1016/s1085-5629(97)80005-3. Semin Cutan Med Surg. 1997. PMID: 9220550 Review.
Cited by
-
Pediatric melanoma: incidence, treatment, and prognosis.Pediatric Health Med Ther. 2017 Apr 18;8:39-45. doi: 10.2147/PHMT.S115534. eCollection 2017. Pediatric Health Med Ther. 2017. PMID: 29388632 Free PMC article. Review.
-
Clinical and dermoscopic characterization of pediatric and adolescent melanomas: Multicenter study of 52 cases.J Am Acad Dermatol. 2018 Feb;78(2):278-288. doi: 10.1016/j.jaad.2017.09.065. Epub 2017 Oct 9. J Am Acad Dermatol. 2018. PMID: 29024734 Free PMC article.
-
Pathology and genomics of pediatric melanoma: A critical reexamination and new insights.Pediatr Blood Cancer. 2018 Feb;65(2):10.1002/pbc.26792. doi: 10.1002/pbc.26792. Epub 2017 Sep 12. Pediatr Blood Cancer. 2018. PMID: 28895292 Free PMC article. Review.
-
Survival from skin cancer and its associated factors in Kurdistan province of Iran.Med J Islam Repub Iran. 2015 Oct 12;29:277. eCollection 2015. Med J Islam Repub Iran. 2015. PMID: 26793668 Free PMC article.
References
-
- Downard CD, Rapkin LB, Gow KW. Melanoma in children and adolescents. Surg Oncol. 2007;16:215–220. - PubMed
-
- Strouse JJ, Fears TR, Tucker MA, et al. Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end results database. J Clin Oncol. 2005;23:4735–4741. - PubMed
-
- Livestro DP, Kaine EM, Michaelson JS, et al. Melanoma in the young: differences and similarities with adult melanoma: a case-matched controlled analysis. Cancer. 2007;110:614–624. - PubMed
-
- Saenz NC, Saenz-Badillos J, Busam K, et al. Childhood melanoma survival. Cancer. 1999;85:750–754. - PubMed
-
- Mills O, Messina JL. Pediatric melanoma: a review. Cancer Control. 2009;16:225–233. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical